Investing.commacroeconomiaNEUTRALLOWBreaking

CRISPR Therapeutics names Sivakesava Sakhamuri as CTO

No summary available

Read at Investing.com

Also reported by

Also reported bySeeking Alpha
CRISPR Therapeutics names Sivakesava Sakhamuri as CTO